| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | -8.29M | 32.47M | 13.41M | -3.17M | 35.09M |
| Gross Profit | -9.63M | 31.48M | 11.53M | -4.73M | 34.41M |
| EBITDA | -10.23M | 30.77M | 0.00 | 0.00 | 0.00 |
| Net Income | -11.78M | 30.10M | 10.38M | -4.37M | 33.94M |
Balance Sheet | |||||
| Total Assets | 270.15M | 310.78M | 391.11M | 237.04M | 246.51M |
| Cash, Cash Equivalents and Short-Term Investments | 3.27M | 1.47M | 6.38M | 1.57M | 865.00K |
| Total Debt | 15.08M | 15.14M | 15.45M | 15.79M | 15.00M |
| Total Liabilities | 15.71M | 16.23M | 76.76M | 17.81M | 16.86M |
| Stockholders Equity | 254.45M | 294.55M | 314.35M | 219.24M | 229.66M |
Cash Flow | |||||
| Free Cash Flow | 0.00 | 47.57M | 31.10M | 7.16M | 12.49M |
| Operating Cash Flow | 6.59M | 47.57M | 31.10M | 7.16M | 12.49M |
| Investing Cash Flow | 23.65M | 0.00 | 0.00 | 1.40M | 6.44M |
| Financing Cash Flow | -28.44M | -52.48M | -26.30M | -6.46M | -12.45M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | £208.16M | 4.34 | 12.32% | 8.15% | 0.66% | 11.49% | |
79 Outperform | £736.59M | 5.68 | 30.00% | 8.73% | 7.71% | -7.39% | |
78 Outperform | £1.88B | 12.41 | 2.24% | 2.40% | 68.95% | 109.67% | |
74 Outperform | £787.15M | 2.52 | 11.49% | 2.70% | 16.37% | 58.77% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | ― | -3.72 | 9.89% | 3.91% | -124.80% | -145.02% | |
53 Neutral | £822.29M | -114.93 | 5.07% | 2.47% | -88.06% | -107.88% |